Back to News
Market Impact: 0.1
Open-Medicine AI: Lantern Pharma to Present the Agentic AI Drug Development Market, User Needs, Development Roadmap, Platform Economics, and Benchmarks, Today at 12:30 PM ET
Source: Business Wire
Artificial IntelligenceHealthcare & BiotechTechnology & Innovation
Lantern Pharma announced that its Open-Medicine AI unit will present on the agentic AI drug-development market, user needs, product-development roadmap, platform economics, and benchmarking. The provided article text contains no financial results, forecasts, product metrics, or transaction details, limiting the immediate market significance.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
LTRN0.45
More News
- CoreWeave seeks truce with Texas Governor-elect Hinojosa
- Cathie Wood 'always feels better when the market is worried' — here's why
- These funds tout hefty income tied to the tech trade – if you’re willing to deal with the complexity
- Street Calls of The Week
- AI stock selloff drives investors to China, India, and overlooked Asian sectors
- Asia Markets Brace for More AI Volatility